Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Price-to-earnings ratio
3Y CAGR
-22.1%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 125.48 | +47.3% |
| 2024 | 85.20 | +605.6% |
| 2023 | -16.85 | -106.4% |
| 2022 | 265.01 | +5671.6% |
| 2021 | -4.76 | +85.4% |
| 2020 | -32.68 | -47.1% |
| 2019 | -22.22 | +49.7% |
| 2018 | -44.16 | -29.0% |
| 2017 | -34.23 | -409.3% |
| 2016 | -6.72 | - |